Related Experiment Video
Updated: Jan 23, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Second generation antihistamines: an update
Mario Sánchez-Borges1, Ignacio J Ansotegui2
1Allergy and Clinical Immunology Department, Centro Médico Docente La Trinidad and Clínica El Avila, Caracas, Venezuela.
Purpose Of Review:
This article presents an update on the clinical pharmacology, mechanisms of action, and safety of second generation antihistamines (SGAHs).
Recent Findings:
Recent research has shown the efficacy and good tolerance of SGAHs supporting its indication as first line medications for the treatment of allergic rhinoconjunctivitis and urticaria.
Summary:
The information contained in this review is relevant for the correct utilization of SGAHs by practicing physicians who take care of these highly prevalent clinical disorders.
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
DC Generator
Generation Time
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Generator Voltage Control
Generation of Three-Phase Voltage
As the rotor...

